Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-06 8:27 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
3,921 | $21.38 | $83,836 | 51,704 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-06 8:18 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
14,519 | $1.1361 | $16,496 | 349,093 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-06 5:41 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
5,388 | $1.6602 | $8,945 | 144,612 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
14,725 | $0 | 14,725 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
34,505 | $0 | 70,413 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-26 8:01 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2024-02-28 Option Award |
2024-03-01 7:15 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
158,500 | $0 | 158,500 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 9:17 pm |
N/A 2034-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
366,000 | $0 | 520,612 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
290,000 | $0 | 410,000 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-30 4:30 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
150,000 | $0 | 160,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 7:08 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
137,500 | $0 | 137,500 (Direct) |
View |
| 2020-08-19 Option Award |
2020-08-20 7:19 pm |
N/A 2030-08-19 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
250,000 | $0 | 250,000 (Direct) |
View |